Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2020-07-06
2020-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The effect of two different dietary fiber supplements is tested (arabinoxylan \& ß-glucan versus inulin \& fructooligosaccharides) in a randomized crossover intervention trial including healthy volunteers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Fibers Effect on the Gut Microbiota Composition
NCT04114513
Fiber Fermentation, and Short Chain Fatty Acid Kinetics and Utilization Inside the Gut and Systemic Circulation
NCT04499183
Fabulous Fibre Study - Effect of Wheat Bran Extract on Gut and General Health in Healthy Aging Subjects (FFS)
NCT02693782
Fiber Blends and Gut Microbiota (FB)
NCT04101344
Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers
NCT03773900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
This arm received the arabinoxylan/ß-glucan mix first.
Dietary fiber supplementation
1. 16g/day: mix of 70% wheat-bran arabinoxylan and 30% oat-derived fiber (ß-glucan)
2. 16g/day: mix of 50% inulin and 50% oligofructose from chicory
2
This arm received the inulin/oligofructose mix first.
Dietary fiber supplementation
1. 16g/day: mix of 70% wheat-bran arabinoxylan and 30% oat-derived fiber (ß-glucan)
2. 16g/day: mix of 50% inulin and 50% oligofructose from chicory
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary fiber supplementation
1. 16g/day: mix of 70% wheat-bran arabinoxylan and 30% oat-derived fiber (ß-glucan)
2. 16g/day: mix of 50% inulin and 50% oligofructose from chicory
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* signed written informed consent
* willingness not to change the dietary pattern in the course of the study
Exclusion Criteria
* acute or chronic gastrointestinal symptoms
* neoplastic diseases
* very strict diets, including raw foodists and frutarians
* regular smoking (more than one box per day)
* intake of antibiotics, immunosuppressants, or any intestinal therapeutics three months prior to study begin
* supplementation of fibers three months prior to study begin
* simultaneous participation in another clinical study
* pregnancy / breastfeeding
* relevant violations of the study protocol
* intolerance to the fiber supplements (including wheat, oat, chicory)
* occurrence of relevant diseases (individual decision by study physicians)
* revocation of consent
* placement in a clinic or similar facility based on an official or court order
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Hohenheim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephan C. Bischoff, MD, Professor
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephan C Bischoff, Prof., MD
Role: PRINCIPAL_INVESTIGATOR
University of Hohenheim, Institute of Nutritional Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Nutritional Medicine, University of Hohenheim
Stuttgart, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FiberStudy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.